Full Press Release Details
Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq
PARIS, FRANCE December 18, 2018 - Sanofi today
announced that it will be transferring the listing of its American Depositary Shares (ADS) from the New York Stock Exchange (NYSE) to The Nasdaq Global Select Market (Nasdaq) effective December 31, 2018, after market close. Sanofi s ADSs
are expected to begin trading as a Nasdaq-listed security at market open on January 2, 2019, and will continue to be listed under the ticker symbol SNY. This transition will not impact the company s primary listing on Euronext
This partnership with Nasdaq is a natural transition for Sanofi as it provides greater
cost-efficiencies as well as access to a broad-based portfolio of investor relations tools to enhance both market insights and our interaction with the financial community, said Jean-Baptiste Chasseloup de Chatillon, Executive Vice President,
Chief Financial Officer, Sanofi. I want to thank the NYSE which was our listing partner in the U.S. for many years.
Sanofi is dedicated to supporting people through their health
challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with
long-term chronic conditions.
With more than 100,000 people
in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Sanofi, Empowering Life
| Media Relations Contact Ashleigh Koss Tel.: +33 (0)1 53 77 46 46 mr@sanofi.com | Investor Relations Contact George Grofik Tel.: +33 (0)1 53 77 45 45 ir@sanofi.com | |||
| Sanofi Forward-Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are |